Gardner’s Syndrome: Colon Polyps, Bone Growths, and Cancer

Gardner’s syndrome is a variant of familial adenomatous polyposis (FAP), an inherited condition driven by mutations in the APC gene, that causes hundreds to thousands of polyps in the colon along with a distinctive set of growths outside the gut: bone tumors, skin cysts, dental abnormalities, and soft-tissue masses called desmoid tumors. Left untreated, the colon polyps progress to cancer in the vast majority of cases, making early detection and preventive surgery central to managing the condition. What makes Gardner’s syndrome particularly tricky is that some of its earliest visible signs show up not in the gut but in the jaw, the skin, or the eyes, sometimes years before any polyps are found.

What Gardner’s Syndrome Actually Is

Gardner’s syndrome is not a separate disease from familial adenomatous polyposis. It is a phenotypic variant, meaning the underlying genetic defect is the same, but the combination of symptoms looks different on the surface. Classic FAP is defined primarily by the carpet of adenomatous polyps that line the colon, typically numbering over a hundred. Gardner’s syndrome includes those polyps plus a collection of extracolonic features: osteomas (benign bone growths), epidermoid cysts in the skin, desmoid tumors in soft tissue, dental abnormalities, and sometimes other tumors. The distinction between “plain” FAP and Gardner’s syndrome is clinical rather than genetic; both stem from mutations in the same gene, and whether someone develops the full Gardner’s picture depends partly on where within that gene the mutation falls.

The syndrome was first described in 1951 by Eldon J. Gardner, a genetics professor who recognized the triad of colonic polyposis, osteomas, and soft-tissue tumors as a single inherited condition. It follows an autosomal dominant inheritance pattern with high penetrance, meaning that a child who inherits the mutated gene from one parent will almost certainly develop the condition. The responsible gene, APC, sits on chromosome 5, and its protein product normally acts as a brake on cell growth. When the gene is disrupted, that brake fails, and cells in the colon lining and elsewhere begin growing unchecked.

The Genetic Picture

All forms of FAP trace back to germline mutations in the APC gene, and nearly all of those mutations produce a truncated, nonfunctional version of the APC protein. In one study of Swedish FAP and Gardner’s syndrome families, disease-causing germline mutations resulting in APC protein truncation were identified in six of seven patients tested.¹ Those mutations can occur at different points along the gene, and the location matters. Research has shown that families with mutations past codon 1444 tend to develop more severe extracolonic features: more osteomas and dental abnormalities visible on imaging, and what appears to be a higher rate of desmoid tumors.² This genotype-phenotype correlation is one reason clinicians pay close attention to the exact mutation when counseling families about what to expect.

Because inheritance is autosomal dominant, each child of an affected parent has a fifty-fifty chance of inheriting the mutation. Genetic testing can identify carriers with high accuracy. When the specific mutation in a family is already known, direct sequencing of that region of the APC gene has been shown to be roughly 90% accurate and cost-effective. Other screening methods, including linkage analysis and protein truncation testing, reach accuracies in the range of 70% to 90%.³ For at-risk family members, genetic testing is the most efficient way to determine who carries the gene and who does not, sparing non-carriers from years of unnecessary surveillance.

Colon Polyps and the Path to Cancer

The defining gastrointestinal feature of Gardner’s syndrome is the same as in classic FAP: the colon becomes studded with adenomatous polyps, often in the hundreds or thousands. These polyps are not immediately dangerous, but each one carries the potential to turn malignant over time. The progression from polyp to cancer is not a question of “if” but “when.” Without treatment, the majority of patients develop colorectal carcinoma by age 40 to 50.⁴ That near-certainty of cancer is the central reason prophylactic surgery plays such a prominent role in management.

Polyps typically begin appearing in the teens, which is why screening guidelines recommend colonoscopy starting at age 10 to 12 for anyone known to carry an APC mutation.⁵ Polyps can also develop in the upper gastrointestinal tract, particularly the duodenum, which requires its own surveillance. The stomach and small bowel are not immune to the effects of a broken APC gene, and duodenal cancer is the leading cause of cancer death among FAP patients who have already had their colons removed.

Bone Growths and Dental Clues

Osteomas are one of the most recognizable features that set Gardner’s syndrome apart from ordinary FAP. These are benign, hard, bony lumps that most commonly appear in the jaws and skull, particularly the frontal bone and the angle of the mandible. They are usually painless and slow-growing, but they can become large enough to cause cosmetic concerns or, occasionally, compress nearby structures.

The dental abnormalities that accompany Gardner’s syndrome are remarkably varied and turn up in a high proportion of patients. Estimates range from about 30% to 75% depending on the study.⁶ Other reports put that figure around 70%.⁷ These dental anomalies include:

Impacted teeth: teeth that fail to erupt normally and remain trapped in the jawbone.
Supernumerary teeth: extra teeth beyond the normal count.
Odontomas: disorganized masses of dental tissue that appear as small, round opacities on X-rays.
Congenitally missing teeth: teeth that never form at all.

When osteomas and dental anomalies appear together, the combination is highly suggestive of Gardner’s syndrome.⁸ Because these skeletal and dental features can appear in childhood or adolescence, often before any intestinal polyps are detected, dentists and oral surgeons are sometimes the first clinicians to raise the suspicion of Gardner’s syndrome. A routine panoramic dental X-ray showing multiple impacted teeth, odontomas, and bony lumps in the jaw of a young person should prompt further investigation, especially if there is a family history of colon polyps or colorectal cancer.

Skin and Soft-Tissue Manifestations

Epidermoid cysts are among the most common non-intestinal findings in Gardner’s syndrome, present in roughly half to two-thirds of patients.⁹ These firm, round, painless lumps usually appear under the skin of the face, scalp, or extremities. They tend to show up before puberty, which can make them one of the earliest signs of the syndrome. While they sometimes become inflamed or rupture, they do not turn malignant. Their real significance is as a flag for clinicians: a young person developing multiple epidermoid cysts, especially in combination with bony lumps, warrants a look at the family history and potentially genetic testing.

Desmoid tumors are a different matter entirely. These are fibrous growths that arise in connective tissue, particularly in the mesentery (the membrane that anchors the intestines inside the abdomen) and the abdominal wall. Unlike epidermoid cysts, desmoid tumors can cause serious problems. They do not metastasize the way a classic cancer does, but they are locally aggressive, growing into surrounding structures and sometimes compressing blood vessels, the intestines, or the ureters. Mesenteric desmoids in particular can contribute to significant illness and even death.¹⁰ A long-term study of one family carrying an APC mutation found that recurrent desmoid tumors were a major determinant of outcome across three generations.¹¹ Desmoids sometimes arise after abdominal surgery, making their management a delicate balancing act: the patient needs their colon removed to prevent cancer, but the surgery itself can trigger desmoid formation.

Eye Findings

A subtle but diagnostically useful feature of Gardner’s syndrome is congenital hypertrophy of the retinal pigment epithelium, or CHRPE. These are small, flat, darkly pigmented spots on the retina that can be seen during a routine dilated eye exam. A single CHRPE lesion can occur in anyone and means nothing. But multiple bilateral CHRPE lesions, especially those with certain characteristic features, are strongly associated with FAP and Gardner’s syndrome.¹² The lesions do not impair vision and do not require treatment, but their presence in an at-risk individual can help confirm a suspected diagnosis or prompt genetic testing. Eye care professionals who notice the pattern during a routine exam are in a position to flag the finding for further workup, much as a dentist might flag suspicious jaw osteomas.

Cancers Beyond the Colon

Although colorectal cancer gets the most attention, Gardner’s syndrome raises the risk of several other malignancies. Thyroid cancer is the most common extracolonic endocrine tumor seen in these patients, with young women being disproportionately affected.¹³ The thyroid tumors associated with FAP and Gardner’s syndrome tend to be of the papillary or cribriform-morular variant, which generally carries a favorable prognosis when caught early. Periodic thyroid screening, typically by physical exam and ultrasound, is therefore part of the recommended surveillance for affected individuals.

Duodenal and periampullary cancers are another concern. As mentioned earlier, once the colon has been removed, the duodenum becomes the most common site for cancer in FAP patients. Upper endoscopy is used to monitor for precancerous changes in the duodenum. Other tumors that have been reported at increased frequency include hepatoblastoma in young children, brain tumors (particularly medulloblastomas, in a subset historically called Turcot syndrome), and adrenal tumors. None of these are common even in Gardner’s syndrome families, but they illustrate the far-reaching consequences of losing APC function.

Surgical Approaches to Prevention

Because the colon will almost certainly develop cancer if left in place, prophylactic colectomy is the cornerstone of Gardner’s syndrome management. The timing matters: too early and you impose a major surgery on a teenager; too late and you risk a polyp that has already become malignant. Most centers aim to perform surgery in the late teens or early twenties, though the decision depends on polyp burden and individual circumstances.

The traditional approach is total abdominal colectomy with ileorectal anastomosis, where the colon is removed but the rectum is preserved and reconnected to the small intestine. Long-term follow-up studies have shown this to be effective: in one series of 26 patients followed for up to 28 years, none developed rectal adenocarcinoma, provided they underwent regular surveillance of the remaining rectal segment and had any new polyps destroyed.¹⁴ A key detail from another study is that performing the anastomosis at a measured 12 cm level appeared to promote regression of rectal polyps in the majority of patients treated that way.¹⁵

The alternative is restorative proctocolectomy with ileal pouch-anal anastomosis, which removes both the colon and rectum and creates a reservoir from the small bowel. This eliminates the cancer risk in the rectum but comes with its own complications, including the possibility of chronic inflammation of the pouch (pouchitis), which can be difficult to treat and may impair quality of life. The choice between the two approaches involves weighing cancer risk in a retained rectum against the functional trade-offs of a pouch. In both cases, patients with a strong family history of desmoid tumors need especially careful surgical planning, because abdominal surgery can trigger desmoid growth.

Drug Therapies for Polyp Reduction

Surgery remains the primary tool, but medications have shown some ability to shrink polyps or slow their growth. The best-studied drug in this context is sulindac, a nonsteroidal anti-inflammatory agent. Clinical reports have documented complete regression of colonic polyps in Gardner’s syndrome patients treated with sulindac. In one case, three patients experienced total polyp regression after two to three months of therapy.¹⁶ In another, a 22-year-old woman with Gardner’s syndrome saw her colonic adenomas disappear entirely after about 40 months of sulindac at 100 mg twice daily, with the effect holding for at least 51 months.¹⁷

These results are striking, but there are important caveats. The effect of sulindac tends to be temporary; polyps often return when the drug is stopped. Sulindac does not eliminate the need for surgery, but it may be useful for postponing colectomy, particularly in patients with a relatively sparse polyp burden. And it has not been proven to prevent cancer independently of surgery, so it is considered an adjunct, not a replacement.

Newer chemopreventive agents are under active investigation. Clinical trials have been testing rapamycin (in an encapsulated oral form), metformin, and other drugs in FAP patients to see whether they can reduce polyp burden after risk-reduction surgery.¹⁸ Early-phase trials of encapsulated rapamycin showed promising enough results that researchers planned to move into larger efficacy studies.¹⁹ If any of these approaches prove effective, they could extend the interval before surgery is needed or reduce the polyp burden in parts of the gastrointestinal tract that surgery cannot easily reach, like the duodenum.

Attenuated FAP and Diagnostic Overlap

One source of confusion is the distinction between classic FAP, Gardner’s syndrome, and attenuated FAP (aFAP). Classic FAP generally produces more than 100 grossly detectable colonic polyps, while attenuated FAP has fewer than 100 and tends to produce polyps in a more proximal location within the colon. Gardner’s syndrome can technically overlap with either, since it is defined by the presence of extracolonic features rather than a specific polyp count. In practice, the terms describe a spectrum rather than discrete boxes. Two members of the same family carrying the identical APC mutation can present differently: one might develop osteomas and desmoid tumors along with their polyps, while the other has only the colonic disease. The position of the mutation influences the odds of extracolonic features, but does not guarantee them.

Because of this variability, some clinicians and researchers have argued that the separate name “Gardner’s syndrome” is misleading and that all these presentations should simply be grouped under the FAP umbrella. Others maintain that the label is useful precisely because it alerts physicians to look beyond the colon. Whatever the terminology, the practical message is the same: anyone diagnosed with FAP should be monitored for the extracolonic features historically associated with Gardner’s syndrome, and anyone who presents with those extracolonic features should be evaluated for colon polyps.

Why Dentists, Dermatologists, and Eye Doctors Matter

One of the most actionable takeaways about Gardner’s syndrome is that it frequently announces itself to clinicians who are not gastroenterologists. A teenager with multiple impacted teeth, jaw osteomas, and a few unusual lumps under the skin may be sitting in a dentist’s chair, not a GI clinic. An eye doctor performing a routine dilated exam might notice the distinctive CHRPE pattern. A dermatologist might see a child with an unusual number of epidermoid cysts. In each case, recognizing the pattern and connecting it to the possibility of an inherited polyposis syndrome can be lifesaving, because it triggers the genetic testing and colonoscopy that catches polyps before they become cancer.

The importance of that recognition is underscored by what happens without it. In the multi-generational family study mentioned earlier, four patients who declined screening endoscopy developed invasive cancers of the colon and stomach.²⁰ Early surveillance and timely surgery can prevent those outcomes. Every specialist who encounters a young patient with even one of the classic extracolonic features of Gardner’s syndrome has an opportunity to start that process.